The new first-line defense: the potential of nasopharyngeal colonization in vaccine strategies

References

• Watson K, Carville K, Bowman J, et al. Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia. Pediatr Infect Dis J. 2006;25(9):782–790.
   Web of Science ®Google Scholar
• Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol. 2008;6(4):288–301.
   PubMed Web of Science ®Google Scholar
• Simell B, Auranen K, Käyhty H, et al; Pneumococcal Carriage Group. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. 2012;11(7):841–855.
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7(12):887–894.
   PubMed Web of Science ®Google Scholar
• Regev-Yochay G, Dagan R, Raz M, et al. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children. JAMA. 2004;292(6):716–720.
   PubMed Web of Science ®Google Scholar
• Bogaert D, De Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4(3):144–154.
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Hermansen MN, Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med. 2007;357(15):1487–1495.
   PubMed Web of Science ®Google Scholar
• Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010;5(1):e8578.
   PubMed Web of Science ®Google Scholar
• Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD. Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol. 2013;131(2):346–52.e1–3.
   Web of Science ®Google Scholar
• Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One. 2011;6(2):e16384.
   PubMed Web of Science ®Google Scholar
• Sze MA, Dimitriu PA, Hayashi S, et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1073–1080.
   PubMed Web of Science ®Google Scholar
• Herbst T, Sichelstiel A, Schär C, et al. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am J Respir Crit Care Med. 2011;184(2):198–205.
   PubMed Web of Science ®Google Scholar
• Hagner S, Harb H, Zhao M, et al. Farm-derived Gram-positive bacterium Staphylococcus sciuri W620 prevents asthma phenotype in HDM- and OVA-exposed mice. Allergy. 2013;68(3):322–329.
   PubMed Web of Science ®Google Scholar
• Cahenzli J, Köller Y, Wyss M, Geuking MB, McCoy KD. Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell Host Microbe. 2013;14(5):559–570.
   Web of Science ®Google Scholar
• Richards L, Ferreira DM, Miyaji EN, Andrew PW, Kadioglu A. The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. Immunobiology. 2010;215(4):251–263.
   Web of Science ®Google Scholar
• Cohen JM, Khandavilli S, Camberlein E, Hyams C, Baxendale HE, Brown JS. Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation. PLoS One. 2011;6(10):e25558.
   PubMed Web of Science ®Google Scholar
• Cohen JM, Chimalapati S, de Vogel C, van Belkum A, Baxendale HE, Brown JS. Contributions of capsule, lipoproteins and duration of colonisation towards the protective immunity of prior Streptococcus pneumoniae nasopharyngeal colonisation. Vaccine. 2012;30(30):4453–4459.
   Web of Science ®Google Scholar
• Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest. 2009;119(7):1899–1909.
   PubMed Web of Science ®Google Scholar
• Wilson R, Cohen JM, José RJ, de Vogel C, Baxendale H, Brown JS. Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses. Mucosal Immunol. 2015;8(3):627–639.
   PubMed Web of Science ®Google Scholar
• Wright AKA, Bangert M, Gritzfeld JF, et al. Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung. PLoS Pathog. 2013;9(3):e1003274.
   Web of Science ®Google Scholar
• Ferreira DM, Neill DR, Bangert M, et al. Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med. 2013;187(8):855–864.
   PubMed Web of Science ®Google Scholar
• Gray BM, Dillon HC Jr. Epidemiological studies of Streptococcus pneumoniae in infants: antibody to types 3, 6, 14, and 23 in the first two years of life. J Infect Dis. 1988;158(5):948–955.
   PubMed Web of Science ®Google Scholar
• Loda FA, Collier AM, Glezen WP, Strangert K, Clyde WA Jr, Denny FW. Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr. 1975;87(6 pt 2):1087–1093.
   Web of Science ®Google Scholar
• Syrjänen RK, Kilpi TM, Kaijalainen TH, Herva EE, Takala AK. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J Infect Dis. 2001;184(4):451–459.
   Web of Science ®Google Scholar
• Regev-Yochay G, Raz M, Dagan R, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis. 2004;38(5):632–639.
   Web of Science ®Google Scholar
• Goldblatt D, Hussain M, Andrews N, et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis. 2005;192(3):387–393.
   PubMed Web of Science ®Google Scholar
• Sá-Leão R, Nunes S, Brito-Avô A, et al. High rates of transmission of and colonization by Streptococcus pneumoniae and Haemophilus influenzae within a day care center revealed in a longitudinal study. J Clin Microbiol. 2008;46(1):225–234.
   Web of Science ®Google Scholar
• Gray BM, Converse GM, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis. 1980;142(6):923–933.
   PubMed Web of Science ®Google Scholar
• Abdullahi O, Karani A, Tigoi CC, et al. Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya. J Infect Dis. 2012;206(7):1020–1029.
   PubMed Web of Science ®Google Scholar
• Turner P, Turner C, Jankhot A, et al. A longitudinal study of Streptococcus pneumoniae carriage in a cohort of infants and their mothers on the Thailand-Myanmar border. PLoS One. 2012;7(5):e38271.
   PubMed Web of Science ®Google Scholar
• Kandasamy R, Gurung M, Thapa A, et al. Multi-serotype pneumococcal nasopharyngeal carriage prevalence in vaccine naïve Nepalese children, assessed using molecular serotyping. PLoS One. 2015;10(2):e0114286.
   Web of Science ®Google Scholar
• Kamng’ona AW, Hinds J, Bar-Zeev N, et al. High multiple carriage and emergence of Streptococcus pneumoniae vaccine serotype variants in Malawian children. BMC Infect Dis. 2015;15:234.
   Web of Science ®Google Scholar
• Ekdahl K, Ahlinder I, Hansson HB, et al. Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project. Clin Infect Dis. 1997;25(5):1113–1117.
   Web of Science ®Google Scholar
• Sleeman KL, Griffiths D, Shackley F, et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis. 2006;194(5):682–688.
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893–902.
   PubMed Web of Science ®Google Scholar
• Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375(9730):1969–1987.
   PubMed Web of Science ®Google Scholar
• Walker CLF, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet. 2013;381(9875):1405–1416.
   PubMed Web of Science ®Google Scholar
• Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14(3):e197–e209.
   PubMed Web of Science ®Google Scholar
• Davis SM, Deloria-Knoll M, Kassa HT, O’Brien KL. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine. 2013;32(1):133–145.
   PubMed Web of Science ®Google Scholar
• Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013;1:CD000422.
   Google Scholar
• Yildirim I, Hanage WP, Lipsitch M, et al. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine. 2010;29(2):283–288.
   PubMed Web of Science ®Google Scholar
• Hanage WP, Finkelstein JA, Huang SS, et al. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics. 2010;2(2):80–84.
   PubMed Web of Science ®Google Scholar
• Flasche S, Van Hoek AJ, Sheasby E, et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med. 2011;8(4):e1001017.
   PubMed Web of Science ®Google Scholar
• Biesbroek G, Wang X, Keijser BJF, et al. Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children. Emerg Infect Dis. 2014;20(2):201–210.
   PubMed Web of Science ®Google Scholar
• Spijkerman J, Prevaes SMPJ, van Gils EJM, et al. Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One. 2012;7(6):e39730.
   Google Scholar
• Pericone CD, Overweg K, Hermans PW, Weiser JN. Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun. 2000;68(7):3990–3997.
   PubMed Web of Science ®Google Scholar
• Johnson AP. The pathogenic potential of commensal species of Neisseria. J Clin Pathol. 1983;36(2):213–223.
   Web of Science ®Google Scholar
• Stephens DS. Uncloaking the meningococcus: dynamics of carriage and disease. Lancet. 1999;353(9157):941–942.
   PubMed Web of Science ®Google Scholar
• Cartwright KAV, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect. 1987;99(3):591–601.
   PubMed Web of Science ®Google Scholar
• Caugant DA, Høiby EA, Magnus P, et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol. 1994;32(2):323–330.
   PubMed Web of Science ®Google Scholar
• Davies AL, O’Flanagan D, Salmon RL, Coleman TJ. Risk factors for Neisseria meningitides carriage in a school during a community outbreak of meningococcal infection. Epidemiol Infect. 1996;117(2):259.
   PubMed Web of Science ®Google Scholar
• Boisier P, Nicolas P, Djibo S, et al. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis. 2007;44(5):657–663.
   PubMed Web of Science ®Google Scholar
• Trotter CL, Maiden MCJ. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines. 2009;8(7):851–861.
   PubMed Web of Science ®Google Scholar
• Hepkema H, Pouwels KB, van der Ende A, Westra TA, Postma MJ. Meningococcal serogroup A, C, W123 and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands. PLoS One. 2013;8(5):e65036.
   PubMed Web of Science ®Google Scholar
• Könönen E. Anaerobes in the upper respiratory tract in infancy. Anaerobe. 2005;11(3):131–136.
   Web of Science ®Google Scholar
• Bogaert D, Keijser B, Huse S, et al. Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS One. 2011;6(2):e17035.
   PubMed Web of Science ®Google Scholar
• Hilty M, Qi W, Brugger SD, et al. Nasopharyngeal microbiota in infants with acute otitis media. J Infect Dis. 2012;205(7):1048–1055.
   Web of Science ®Google Scholar
• van der Waaij D, Berghuis-de Vries JM. Lekkerkerk Lekkerkerk-v. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond). 1971;69(3):405–411.
   PubMedGoogle Scholar
• Kamada N, Chen GY, Inohara N, Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013;14(7):685–690.
   PubMed Web of Science ®Google Scholar
• Wescombe PA, Heng NCK, Burton JP, Chilcott CN, Tagg JR. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol. 2009;4(7):819–835.
   Web of Science ®Google Scholar
• Santagati M, Scillato M, Patanè F, Aiello C, Stefani S. Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol Med Microbiol. 2012;65(1):23–31.
   PubMedGoogle Scholar
• Hammami R, Fernandez B, Lacroix C, Fliss I. Anti-infective properties of bacteriocins: an update. Cell Mol Life Sci. 2013;70(16):2947–2967.
   PubMed Web of Science ®Google Scholar
• Iwase T, Uehara Y, Shinji H, et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010;465(7296):346–349.
   PubMed Web of Science ®Google Scholar
• Regev-Yochay G, Trzcinski K, Thompson CM, Lipsitch M, Malley R. SpxB is a suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model. J Bacteriol. 2007;189(18):6532–6539.
   Web of Science ®Google Scholar
• Shakhnovich EA, King SJ, Weiser JN. Neuraminidase expressed by Streptococcus pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae: a paradigm for interbacterial competition among pathogens of the human respiratory tract. Infect Immun. 2002;70(12):7161–7164.
   PubMed Web of Science ®Google Scholar
• Crowe CC, Sanders WE, Longley S. Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus. J Infect Dis. 1973;128(4):527–532.
   Web of Science ®Google Scholar
• Lysenko ES, Ratner AJ, Nelson AL, Weiser JN. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog. 2005;1(1):e1.
   PubMed Web of Science ®Google Scholar
• Turner P, Turner C, Green N, et al. Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study. Clin Microbiol Infect. 2013;19(12):E551–E558.
   PubMed Web of Science ®Google Scholar
• Soininen A, Pursiainen H, Kilpi T, Käyhty H. Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children. J Infect Dis. 2001;184(5):569–576.
   Web of Science ®Google Scholar
• Musher DM, Groover JE, Reichler MR, et al. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis. 1997;24(3):441–446.
   Web of Science ®Google Scholar
• Salt P, Banner C, Oh S, et al. Social mixing with other children during infancy enhances antibody response to a pneumococcal conjugate vaccine in early childhood. Clin Vaccine Immunol. 2007;14(5):593–599.
   Google Scholar
• Lebon A, Verkaik NJ, Labout JAM, et al. Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study. Infect Immun. 2011;79(4):1680–1687.
   Web of Science ®Google Scholar
• Rapola S, Jäntti V, Haikala R, et al. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis. 2000;182(4):1146–1152.
   Web of Science ®Google Scholar
• Simell B, Ahokas P, Lahdenkari M, et al. Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children. Vaccine. 2009;27(34):4615–4621.
   Web of Science ®Google Scholar
• Prevaes SMPJ, van Wamel WJB, de Vogel CP, et al. Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage. Infect Immun. 2012;80(6):2186–2193.
   PubMed Web of Science ®Google Scholar
• McCool TL, Cate TR, Moy G, Weiser JN. The immune response to pneumococcal proteins during experimental human carriage. J Exp Med. 2002;195(3):359–365.
   PubMed Web of Science ®Google Scholar
• Jefferies JMC, Johnston CHG, Kirkham L-AS, et al. Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. J Infect Dis. 2007;196(6):936–944.
   Web of Science ®Google Scholar
• Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008;4(9):e1000159.
   PubMed Web of Science ®Google Scholar
• Roche A, Richard AL, Rahkola JT, Janoff EN, Weiser JN. Antibody blocks acquisition of bacterial colonization through agglutination. Mucosal Immunol. 2015;8(1):176–185.
   PubMed Web of Science ®Google Scholar
• Park H-S, Francis KP, Yu J, Cleary PP. Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A Streptococcus. J Immunol. 2003;171(5):2532–2537.
   Web of Science ®Google Scholar
• Wang B, Dileepan T, Briscoe S, et al. Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection. Proc Natl Acad Sci U S A. 2010;107(13):5937–5942.
   PubMed Web of Science ®Google Scholar
• Wright AKA, Ferreira DM, Gritzfeld JF, et al. Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage. PLoS Pathog. 2012;8(4):e1002622.
   PubMed Web of Science ®Google Scholar
• Kremastinou J, Tzanakaki G, Pagalis A, Theodondou M, Weir DM, Blackwell CC. Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica. FEMS Immunol Med Microbiol. 1999;24(1):73–78.
   Google Scholar
• Jones GR, Christodoulides M, Brooks JL, Miller ARO, Cartwright KAV, Heckels JE. Dynamics of carriage of Neisseria meningitidis in a group of military recruits: subtype stability and specificity of the immune response following colonization. J Infect Dis. 1998;178(2):451–459.
   PubMed Web of Science ®Google Scholar
• Robinson K, Neal KR, Howard C. Characterization of humoral and cellular immune responses elicited by meningococcal carriage. Infect Immun. 2002;70(3):1301–1309.
   Web of Science ®Google Scholar
• Sánchez S, Troncoso G, Ferreirós C, Criado M. Evaluation of cross-reactive antigens as determinants of cross-bactericidal activity in pathogenic and commensal Neisseria. Vaccine. 2001;19(25–26):3390–3398.
   Web of Science ®Google Scholar
• Sánchez S, Troncoso G, Criado MT, Ferreirós C. In vitro induction of memory-driven responses against Neisseria meningitidis by priming with Neisseria lactamica. Vaccine. 2002;20(23–24):2957–2963.
   Google Scholar
• Frey SE, Lottenbach KR, Hill H, et al. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA. Vaccine. 2013;31(42):4874–4880.
   PubMed Web of Science ®Google Scholar
• Tennant SM, Levine MM. Live attenuated vaccines for invasive Salmonella infections. Vaccine. 2015;33(suppl 3):C36–C41.
   PubMed Web of Science ®Google Scholar
• Alvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis. 2001;32(11):1567–1576.
   PubMed Web of Science ®Google Scholar
• Niittynen L, Pitkäranta A, Korpela R. Probiotics and otitis media in children. Int J Pediatr Otorhinolaryngol. 2012;76(4):465–470.
   Web of Science ®Google Scholar
• Glück U, Gebbers J-O. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr. 2003;77(2):517–520.
   Web of Science ®Google Scholar
• Hatakka K, Savilahti E, Pönkä A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ. 2001;322(7298):1327.
   PubMedGoogle Scholar
• Hatakka K, Blomgren K, Pohjavuori S, et al. Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study. Clin Nutr. 2007;26(3):314–321.
   PubMed Web of Science ®Google Scholar
• Bernstein JM, Sagahtaheri-Altaie S, Dryja DM, Wactawski-Wende J. Bacterial interference in nasopharyngeal bacterial flora of otitis-prone and non-otitis-prone children. Acta Otorhinolaryngol Belg. 1994;48(1):1–9.
   Google Scholar
• Bernstein JM, Haase E, Hasse E, et al. Bacterial interference of penicillin-sensitive and -resistant Streptococcus pneumoniae by Streptococcus oralis in an adenoid organ culture: implications for the treatment of recurrent upper respiratory tract infections in children and adults. Ann Otol Rhinol Laryngol. 2006;115(5):350–356.
   Web of Science ®Google Scholar
• Di Pierro F, Donato G, Fomia F, et al. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media. Int J Gen Med. 2012;5:991–997.
   PubMedGoogle Scholar
• Di Pierro F, Adami T, Rapacioli G, Giardini N, Streitberger C. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opin Biol Ther. 2013;13(3):339–343.
   PubMed Web of Science ®Google Scholar
• Villena J, Barbieri N, Salva S, Herrera M, Alvarez S. Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat-killed Lactobacillus casei. Microbiol Immunol. 2009;53(11):636–646.
   PubMed Web of Science ®Google Scholar
• Salva S, Villena J, Alvarez S. Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections. Int J Food Microbiol. 2010;141(1–2):82–89.
   PubMed Web of Science ®Google Scholar
• Roos K, Håkansson EG, Holm S. Effect of recolonisation with “interfering” alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. BMJ. 2001;322(7280):210–212.
   PubMedGoogle Scholar
• Tano K, Grahn Håkansson E, Holm SE, Hellström S. A nasal spray with alpha-haemolytic streptococci as long term prophylaxis against recurrent otitis media. Int J Pediatr Otorhinolaryngol. 2002;62(1):17–23.
   Web of Science ®Google Scholar
• Troncoso G, Sánchez S, Moreda M, Criado MT, Ferreirós CM. Antigenic cross-reactivity between outer membrane proteins of Neisseria meningitidis and commensal Neisseria species. FEMS Immunol Med Microbiol. 2000;27(2):103–109.
   Google Scholar
• Evans CM, Pratt CB, Matheson M, et al. Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis. Clin Infect Dis. 2011;52(1):70–77.
   Google Scholar
• Sánchez S, Abel A, Arenas J, Criado MT, Ferreirós CM. Cross-linking analysis of antigenic outer membrane protein complexes of Neisseria meningitidis. Res Microbiol. 2006;157(2):136–142.
   Web of Science ®Google Scholar
• Vaughan AT, Gorringe A, Davenport V, Williams NA, Heyderman RS. Absence of mucosal immunity in the human upper respiratory tract to the commensal bacteria Neisseria lactamica but not pathogenic Neisseria meningitidis during the peak age of nasopharyngeal carriage. J Immunol. 2009;182(4):2231–2240.
   Web of Science ®Google Scholar
• Roche AM, King SJ, Weiser JN. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect Immun. 2007;75(5):2469–2475.
   Web of Science ®Google Scholar
• Wu K, Yao R, Wang H, et al. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice. Vaccine. 2014;32(33):4179–4188.
   Web of Science ®Google Scholar
• Xu X, Wang H, Liu Y, et al. Mucosal immunization with the live attenuated vaccine SPY1 induces humoral and Th2-Th17-regulatory T cell cellular immunity and protects against pneumococcal infection. Infect Immun. 2015;83(1):90–100.
   Web of Science ®Google Scholar
• Kim E-HH, Choi S-YY, Kwon M-KK, et al. Streptococcus pneumoniae pep27 mutant as a live vaccine for serotype-independent protection in mice. Vaccine. 2012;30(11):2008–2019.
   PubMed Web of Science ®Google Scholar
• Rosch JW, Iverson AR, Humann J, et al. A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media. EMBO Mol Med. 2014;6(1):141–154.
   PubMed Web of Science ®Google Scholar
• Chimalapati S, Cohen J, Camberlein E, et al. Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains. Infect Immun. 2011;79(12):4965–4976.
   Web of Science ®Google Scholar
• Cho KH, Caparon MG. tRNA modification by GidA/MnmE is necessary for Streptococcus pyogenes virulence: a new strategy to make live attenuated strains. Infect Immun. 2008;76(7):3176–3186.
   Web of Science ®Google Scholar
• Shippy DC, Fadl AA. Immunological characterization of a gidA mutant strain of Salmonella for potential use in a live-attenuated vaccine. BMC Microbiol. 2012;12:286.
   Web of Science ®Google Scholar
• Cohen JM, Wilson R, Shah P, Baxendale HE, Brown JS. Lack of cross-protection against invasive pneumonia caused by heterologous strains following murine Streptococcus pneumoniae nasopharyngeal colonisation despite whole cell ELISAs showing significant cross-reactive IgG. Vaccine. 2013;31(19):2328–2332.
   Web of Science ®Google Scholar
• Hanniffy SB, Carter AT, Hitchin E, Wells JM. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J Infect Dis. 2007;195(2):185–193.
   Web of Science ®Google Scholar
• Wells JM, Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol. 2008;6(5):349–362.
   PubMed Web of Science ®Google Scholar
• Campos IB, Darrieux M, Ferreira DM, et al. Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge. Microbes Infect. 2008;10(5):481–488.
   PubMed Web of Science ®Google Scholar
• Medina MS, Vintiñi EO, Villena J, Raya RR, Alvarez SG. Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections. Bioeng Bugs. 2014;1(5):313–325.
   Google Scholar
• Gilbert C, Robinson K, Le Page RW, Wells JM. Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis. Infect Immun. 2000;68(6):3251–3260.
   Web of Science ®Google Scholar
• Nierop Groot MN, Godefrooij J, Kleerebezem M. Heterologous expression of the pneumococcal serotype 14 polysaccharide in Lactococcus lactis requires lactococcal epsABC regulatory genes. Appl Environ Microbiol. 2008;74(3):912–915.
   Web of Science ®Google Scholar
• Lee SF, Halperin SA, Wang H, MacArthur A. Oral colonization and immune responses to Streptococcus gordonii expressing a pertussis toxin S1 fragment in mice. FEMS Microbiol Lett. 2002;208(2):175–178.
   Web of Science ®Google Scholar
• Medaglini D, Pozzi G, King TP, Fischetti VA. Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci U S A. 1995;92(15):6868–6872.
   Web of Science ®Google Scholar
• Ciabattini A, Giomarelli B, Parigi R, et al. Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. Vaccine. 2008;26(33):4244–4250.
   Web of Science ®Google Scholar
• Lee SF, Halperin SA, Knight JB, Tait A. Purification and immunogenicity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordonii. Appl Environ Microbiol. 2002;68(9):4253–4258.
   Google Scholar
• Kotloff KL, Wasserman SS, Jones KF, et al. Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A Streptococcus vaccine. Infect Immun. 2005;73(4):2360–2366.
   Web of Science ®Google Scholar
• Ferreira DM, Jambo KC, Gordon SB. Experimental human pneumococcal carriage models for vaccine research. Trends Microbiol. 2011;19(9):464–470.
   Web of Science ®Google Scholar
• Deasy AM, Guccione E, Dale AP, et al. Nasal inoculation of the commensal Neisseria lactamica inhibits carriage of Neisseria meningitidis by young adults: a controlled human infection study. Clin Infect Dis. 2015;60(10):1512–1520.
   PubMed Web of Science ®Google Scholar
• Winokur PL, Chaloner K, Doern GV, Ferreira J, Apicella MA. Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae. J Infect Dis. 2013;208(5):728–738.
   Web of Science ®Google Scholar